Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,183,319
-$3,680,171 QoQ
Shares Held
879,706
-0.6% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#277
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEAPACK GLADSTONE FINANCIAL CORP holds $425,890,657 across 14 Drug Manufacturers - General names. PFE ranks #7 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
412,665 | $104,804,529 | |
| 2 | LLY |
ELI LILLY & Co
|
78,019 | $93,578,336 | |
| 3 | MRK |
Merck & Co., Inc.
|
563,132 | $72,362,462 | |
| 4 | ABBV |
AbbVie Inc.
|
209,332 | $52,676,303 | |
| 5 | AMGN |
Amgen Inc
|
87,050 | $31,522,545 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
439,307 | $25,312,868 | |
| 7 | PFE |
Pfizer Inc
This page
|
879,706 | $21,183,319 | |
| 8 | AZN |
Astrazeneca PLC
|
72,990 | $13,840,363 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,183,319 | 879,706 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $24,863,490 | 885,452 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $21,580,903 | 866,703 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $17,971,475 | 705,317 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $18,042,557 | 744,330 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,115,894 | 714,913 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $19,498,619 | 734,965 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $22,080,524 | 762,976 | Shares | Defined | 2024-11-26 | |
| 2024-06-30 | $17,223,675 | 615,571 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $16,235,775 | 585,073 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $17,064,235 | 592,714 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $17,288,203 | 521,200 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $19,695,912 | 536,966 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $21,947,502 | 537,929 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $28,196,909 | 550,291 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $24,993,304 | 571,145 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $26,212,220 | 499,947 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $25,268,625 | 488,094 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $28,836,063 | 488,333 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $21,004,405 | 488,361 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $16,532,137 | 422,169 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $15,379,706 | 424,502 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $11,822,892 | 321,187 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $10,519,346 | 286,631 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $8,699,548 | 266,041 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $8,552,680 | 262,031 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||